Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia

Archives of Disease in Childhood

Volumn 89, Issue 8, 2004, Pages 785-788

  De Oliveira, B M ^a   Viana, M B ^a   Zani, C L ^b   Romanha, A J ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MERCAPTOPURINE; METHOTREXATE; METHYLMERCAPTOPURINE; TIOGUANINE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RECURRENCE; CHILD; CHILD NUTRITION; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DETERMINATION; FAMILY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCOME; INTERVIEW; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MALNUTRITION; MEDICAL RECORD; NEUTROPHIL; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL;

6-MERCAPTOPURINE; ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INFANT; INTERVIEWS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MOTHERS; NUTRITION DISORDERS; PATIENT COMPLIANCE; POVERTY; RECURRENCE; TUMOR MARKERS, BIOLOGICAL;

EID: 2542589197     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.030775     Document Type: Article

References (35)

1. Pui C-H, Sallan S, Relling MV, et al. International childhood acute lymphoblastic leukemia workshop: Sausalito, CA, 30 November - 1 December 2000. Leukemia 2001;15:707-15.
2. Viana MB, Fernandes RAF, Oliveira BM, et al. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica 2001;86:113-20.
3. Davies HA, Lilleyman JS. Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treat Rev 1995;21:93-103.
4. Smith SD, Rosen D, Trueworthy RC, et al. A reliable method for evaluating drug compliance in children with cancer. Cancer 1979;43:169-73.
5. Lansky SB, Smith SD, Cairns NU, et al. Psychological correlates of compliance. Am J Pediatr Hematol Oncol 1983;5:87-92.
6. Tebbi CK, Cummings KM, Zevon MA, et al. Compliance of pediatric and adolescent cancer patients. Cancer 1986;58:1179-84.
7. MacDougall LG, Wilson TD, Cohn R, et al. Compliance with chemotherapy in childhood leukemia in Africa. S Afr Med J 1989;75:481-4.
8. Festa RS, Tamaroff MH, Chasalow F, et al. Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment. J Pediatr 1992;120:807-11.
9. Snodgrass W, Smith S, Trueworthy R, et al. Pediatric clinical pharmacology of 6-mercaptopurine: lack of compliance as a factor in leukemia relapse. Proc Am Soc Clin Oncol 1984;3:204.
10. Azeemuddin S, Bharmal FM. Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia. J Chromatogr 1988;430:163-9.
11. MacDougall LG, McElligott SE, Ross E, et al. Pattern of 6-mercaptopurine urinary excretion in children with acute lymphoblastic leukemia: urinary assays as a measure of drug compliance. Ther Drug Monit 1992;14:371-5.
12. Davies HA, Lennard L, Lilleyman JS. Variable mercaptopurine metabolism in children with leukaemia: a problem of non-compliance? BMJ 1993;306:1239-40.
13. Lennard L, Welch J, Lilleyman JS. Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance? Br J Cancer 1995;72:1004-6.
14. Lancaster D, Lennard L, Lilleyman JS. Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child 1997;76:365-6.
15. Lau RCW, Matsui D, Greenberg M, et al. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol 1998;30:85-90.
16. Dibley MJ, Goldsby JB, Staehling NW, et al. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-48.
17. WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 1986;64:929-41.
18. Lennard L. Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. J Chromatogr 1987;423:169-78.
19. Dervieux T, Boulieu R. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. Clin Chem 1998;44:551-5.
20. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992;583:83-90.
21. Dean AG, Dean JA, Coulombier D, et al. Epi info, version 6: a word processing, database, and statistics program for public health on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1995.
22. Wright EC. Non-compliance - or how many aunts has Matilda? Lancet 1993;342:909-13.
23. Kyngäs HA, Kroll T, Duff ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health 2000;26:379-88.
24. Matsui DM. Drug compliance in pediatrics. Pediatr Clin North Am 1997;44:1-11.
25. Cameron C. Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nurs 1996;24:244-50.
26. Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999;91:2001-8.
27. Kalwinsky DK, Rivera G, Dahl GV, et al. Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukemia: implications for treatment outcome. Leuk Res 1985;6:817-23.
28. Powell JE, Mendez E, Parkes SE, et al. Factors affecting survival in white and Asian children with acute lymphoblastic leukaemia. Br J Cancer 2000;82:1568-70.
29. Paes CA, Viana MB, Freire RV, et al. Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children. Leuk Res 2003;27:789-94.
30. Bonilla M, Moreno N, Marina N, et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. Am J Pediatr Hematol Oncol 2000;22:495-501.
31. Lilleyman JS, Lennard L. Non compliance with oral chemotherapy in childhood leukaemia. BMJ 1996;313:1219-20.
32. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6.
33. Rogers AS, Miller S, Murphy DA, et al. The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) Program: theory and preliminary results. J Adolesc Health 2001;29S:30-8.
34. Spinetta JJ, Masera G, Eden T, et al. Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer. A report of the SIOP working committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol 2002;38:114-17.
35. Mora JO. A new method for estimating a standardized prevalence of child malnutrition from anthropometric indicators. Bull World Health Organ 1989;67:133-42.